Glenmark Pharmaceuticals Complete Financial Statements

GLENMARK • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015

Complete Financial Data Export

Export complete financial statements for Glenmark Pharmaceuticals (GLENMARK). Downloads include all available records across all periods. For market performance, see the GLENMARK stock price today .

Profitability Ratios

Net Profit Margin 9.83% 2025 data
EBITDA Margin 18.25% 2025 data
Operating Margin 16.00% 2025 data
Return on Assets 3.80% 2025 data
Return on Equity 6.89% 2025 data

Balance Sheet Ratios

Current Ratio 7.53 2025 data
Debt to Equity 1.81 2025 data
Equity Ratio 55.13% 2025 data
Asset Turnover 0.39 2025 data

Year-over-Year Growth Analysis

Comparing Sept 2024 vs Sept 2025
Revenue Growth
+80.3%
Year-over-Year
Net Profit Growth
+71.8%
Year-over-Year
EBITDA Growth
+86.2%
Year-over-Year
Expense Growth
+79.1%
Year-over-Year
Assets Growth
+11.8%
Year-over-Year
Equity Growth
+12.8%
Year-over-Year
Liabilities Growth
+11.8%
Year-over-Year
Operating Cash Flow Growth
-212.5%
Year-over-Year
Investing Cash Flow Growth
-98.7%
Year-over-Year
Financing Cash Flow Growth
+120.1%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020 Sept 2019 Mar 2019 Jun 2019 Dec 2019 Sept 2018 Mar 2018 Jun 2018 Dec 2018 Sept 2017 Mar 2017 Jun 2017 Dec 2017 Sept 2016 Mar 2016 Jun 2016 Dec 2016 Sept 2015 Mar 2015 Jun 2015 Dec 2015
Revenue 6,204 3,232 3,086 3,440 3,814 3,255 3,333 3,281 3,062 3,018 2,625 3,069 3,068 2,903 3,272 3,112 2,838 3,005 3,155 2,879 2,788 2,396 2,787 2,845 2,565 2,285 2,672 2,847 2,317 2,268 2,401 2,253 2,373 2,345 2,148 2,171 2,211 1,986 2,478 1,880 1,754 1,631 1,749
Expenses 5,072 3,068 3,007 2,832 3,005 2,656 2,787 3,071 3,402 2,651 2,792 2,539 2,638 2,346 2,626 2,557 2,337 2,391 2,659 2,400 2,302 1,867 2,257 2,365 2,199 1,981 2,296 2,141 1,953 1,819 2,120 1,868 2,094 1,786 1,881 1,775 2,003 1,590 1,770 1,506 1,682 1,288 1,408
EBITDA 1,132 164 79 608 808 599 546 211 -340 367 -168 530 430 558 646 555 502 614 497 480 487 529 531 480 366 304 376 706 365 449 280 385 279 559 267 396 208 395 708 374 73 343 341
Operating Profit Margin % 16.00% 5.00% 2.00% 17.00% 0.00% 18.00% 16.00% 3.00% -15.00% 12.00% -13.00% 15.00% 11.00% 14.00% 14.00% 18.00% 17.00% 19.00% 15.00% 17.00% 15.00% 19.00% 18.00% 14.00% 13.00% 13.00% 13.00% 16.00% 13.00% 15.00% 16.00% 16.00% 14.00% 23.00% 13.00% 18.00% 9.00% 17.00% 28.00% 20.00% 4.00% 21.00% 19.00%
Depreciation 141 125 130 120 151 118 123 141 135 142 147 146 132 147 152 123 111 113 119 104 126 113 115 94 81 91 106 82 74 79 83 75 69 78 75 69 58 64 63 59 65 65 52
Interest 67 67 58 49 149 40 52 122 109 112 134 83 87 60 97 69 83 76 67 81 99 94 95 90 82 93 96 85 74 79 89 70 70 71 71 63 48 43 62 43 40 42 47
Profit Before Tax 967 8 96 473 555 462 456 -6 -542 151 -403 337 270 408 435 385 338 444 343 339 318 358 348 347 240 160 271 580 249 327 154 273 173 444 154 315 209 348 655 303 -10 257 274
Tax 357 4 49 118 1,770 122 108 56 -139 -22 -72 58 97 197 144 110 104 137 103 105 98 104 100 92 79 51 80 166 97 94 38 59 -11 111 49 92 60 121 178 87 -20 75 78
Net Profit 610 4 47 355 -1,214 340 348 -62 -403 173 -331 279 173 211 291 275 234 307 240 234 220 254 248 256 162 109 191 414 152 233 116 214 184 333 105 224 149 227 477 216 11 183 196
Earnings Per Share (₹) 21.63 0.16 1.66 12.55 -43.17 12.06 12.33 -2.90 -15.18 5.31 -12.45 9.23 5.51 6.82 9.66 9.13 8.29 10.86 7.86 8.29 7.81 9.00 8.80 9.06 5.73 3.87 6.76 14.67 5.37 8.26 4.12 7.59 6.51 11.81 3.71 7.92 5.28 8.04 16.91 7.66 0.39 6.66 6.95

Related Pages for Glenmark Pharmaceuticals

Additional stock information and data for GLENMARK

GLENMARK fair value
Glenmark Pharmaceuticals dividend policy
GLENMARK promoter holding
GLENMARK enterprise value
GLENMARK 52-week chart
GLENMARK earnings report
Glenmark Pharmaceuticals share price chart

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 16,050 14,359 19,372 17,083 15,604 14,685 13,296 12,595 11,764 10,193 9,688
Current Assets 9,296 7,428 9,874 8,282 7,360 6,804 6,697 6,989 6,875 5,904 5,323
Fixed Assets 4,487 4,210 6,202 5,887 5,129 5,029 3,670 3,030 2,755 2,594 2,836
Capital Work in Progress 835 662 1,251 1,010 1,382 1,222 1,399 1,122 708 543 492
Investments 56 790 45 50 25 25 30 15 16 17 0
Other Assets 10,672 8,697 11,873 10,137 9,068 8,410 8,197 8,429 8,285 7,039 6,359
LIABILITIES
Total Liabilities 16,050 14,359 19,372 17,083 15,604 14,685 13,296 12,595 11,764 10,193 9,688
Current Liabilities 1,234 693 4,487 2,956 4,338 4,489 3,670 4,144 4,569 2,564 2,976
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 8,849 7,848 9,839 9,438 7,064 6,070 5,605 5,163 4,492 3,629 3,000
Share Capital 28 28 28 28 28 28 28 28 28 28 27
Reserves & Surplus 8,821 7,820 9,446 9,058 7,036 6,042 5,577 5,135 4,464 3,601 2,973

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -828 -265 625 1,109 1,131 1,392 1,324 1,648 657 345 482
Investing Activities 58 4,387 -515 -316 -662 -774 -883 -1,003 -1,001 -950 -712
Financing Activities 787 -3,906 -78 -521 -442 -445 -739 -469 543 699 199
Net Cash Flow 17 215 33 272 28 174 -297 177 199 93 -31